Myasthenia gravis and COVID-19: clinical characteristics and outcomes (2020)
Camelo-filho, Antonio E; Silva, Andre M. S; Estephan, Eduardo P; Zambon, Antonio A; Mendonca, Rodrigo H; Souza, Paulo V. S; Pinto, Wladimir B. V. R; Oliveira, Acary S. B; Dangoni-Filho, Iron; Zanoteli, Edmar 
Source: Frontiers in neurology. Unidade: FM
Subjects: IMUNOSSUPRESSÃO, COVID-19, MIASTENIA GRAVIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAMELO-FILHO, Antonio E et al. Myasthenia gravis and COVID-19: clinical characteristics and outcomes. Frontiers in neurology, v. 11, 2020Tradução . . Disponível em: https://doi.org/10.3389/fneur.2020.01053. Acesso em: 18 nov. 2024.APA
Camelo-filho, A. E., Silva, A. M. S., Estephan, E. P., Zambon, A. A., Mendonca, R. H., Souza, P. V. S., et al. (2020). Myasthenia gravis and COVID-19: clinical characteristics and outcomes. Frontiers in neurology, 11. doi:10.3389/fneur.2020.01053NLM
Camelo-filho AE, Silva AMS, Estephan EP, Zambon AA, Mendonca RH, Souza PVS, Pinto WBVR, Oliveira ASB, Dangoni-Filho I, Zanoteli E. Myasthenia gravis and COVID-19: clinical characteristics and outcomes [Internet]. Frontiers in neurology. 2020 ; 11[citado 2024 nov. 18 ] Available from: https://doi.org/10.3389/fneur.2020.01053Vancouver
Camelo-filho AE, Silva AMS, Estephan EP, Zambon AA, Mendonca RH, Souza PVS, Pinto WBVR, Oliveira ASB, Dangoni-Filho I, Zanoteli E. Myasthenia gravis and COVID-19: clinical characteristics and outcomes [Internet]. Frontiers in neurology. 2020 ; 11[citado 2024 nov. 18 ] Available from: https://doi.org/10.3389/fneur.2020.01053
